家庭健康科技品牌FITURE完成A輪6,500萬美元融資 騰訊(00700.HK)領投
據內地傳媒報道,家庭科技健康品牌FITURE完成A輪6,500萬美元融資,並由騰訊(00700.HK)領投,C資本、凱輝基金,黑蟻資本、中信產踝基金、BAI及全明星基金跟投,而公司的天使投資者紅杉資本中國基金亦有追加投資。
公司網站網站稱,FITURE為家庭科技健身方式的開創者和引領者,致力通過科技幫助大眾建立健康的生活方式,並通過技術創新為用戶提供了集科技健身硬件、虛擬教練專業指導、海量頂級健身課程、專業健身社區服務在內的科技健身方式服務。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.